SAFETY DATA SHEET

Product name: SPRInt Layer Zero (A)
Brand: SPRInt Medical Group Limited
Published date: 14/02/2026
Revision date: 13/02/2027
Revision number: 1.1

Section 1: Identification of the substance/mixture and of the company/undertaking

1.1 Product identifier

· Product name: SPRInt Layer Zero (A)

· Product category: Ink Product

1.2 Relevant identified uses of the substance or mixture and uses advised against

· Recommended use: UV Printing Operations

· Marketed application statement: High performance medical prototyping UV primer for acrylics.

1.3 Details of the supplier of the safety data sheet

SPRInt Medical Group Limited
49-65 Southampton Way, London, SE5 7SW, England, United Kingdom
Brand owner of SPRInt Layer Zero (A)

1.4 Emergency telephone number

· Emergency telephone number: +44 (0) 333 335 6556

Section 2: Hazards identification

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP]:

· Acute toxicity - Dermal, Category 4 (H312)

· Acute toxicity - Inhalation (Vapors), Category 4 (H332)

· Acute toxicity - Inhalation (Dusts/Mists), Category 4 (H332)

· Skin corrosion/irritation, Category 2 (H315)

· Carcinogenicity, Category 1B (H350)

· Specific target organ toxicity (repeated exposure), Category 2 (H373)

· Aspiration hazard, Category 1 (H304)

· Flammable liquids, Category 3 (H226)

2.2 Label elements

· Signal word: Danger

Hazard statements:

· H226 - Flammable liquid and vapor

· H304 - May be fatal if swallowed and enters airways

· H312 - Harmful in contact with skin

· H315 - Causes skin irritation

· H332 - Harmful if inhaled

· H350 - May cause cancer

· H373 - May cause damage to organs through prolonged or repeated exposure

Precautionary statements:

· P201 - Obtain special instructions before use

· P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking

· P260 - Do not breathe dust/fume/gas/mist/vapors/spray

· P280 - Wear protective gloves/protective clothing/eye protection/face protection

· P301 + P310 - IF SWALLOWED: Immediately call 999 or the National Poisons Information Service on +44 (0) 344 892 0111.

· P331 - Do NOT induce vomiting

· P403 + P233 - Store in a well-ventilated place. Keep container tightly closed

2.3 Other hazards

This mixture contains no substance considered to be persistent, bioaccumulating nor toxic and no substance considered to be very persistent nor very bioaccumulating. This product does not contain any known or suspected endocrine disruptors.

Section 3: Composition/information on ingredients

3.2 Mixtures

Chemical name

EC No

CAS No.

Weight-%

Classification according to Regulation (EC) No. 1272/2008 [CLP]

REACH registration number

Note

Xylenes (o-, m-, p- isomers)

215-535-7

1330-20-7

80 - 100

Acute Tox. 4 (H312); Acute Tox. 4 (H332); Skin Irrit. 2 (H315); Flam. Liq. 3 (H226)

01-2119488216-32-xxxx

1

Ethyl benzene (constituent)

202-849-4

100-41-4

10 - 30

Acute Tox. 4 (H332); STOT RE 2 (H373); Asp. Tox. 1 (H304); Flam. Liq. 2 (H225)

01-2119489370-35-xxxx

1, 2

Cumene (constituent)

202-704-5

98-82-8

0.10 - < 0.50

Carc. 1B (H350); STOT SE 3 (H335); Asp. Tox. 1 (H304); Aquatic Chronic 2 (H411); Flam. Liq. 3 (H226)

01-2119473983-24-xxxx

1, 2

Note: REACH registration number(s) may not be provided because substance(s) are exempted or not yet required to be registered under REACH.

1. Substance with a Community workplace exposure limit.

2. Hazardous constituent contained in complex substance(s) required for disclosure.

Section 4: First aid measures

4.1 Description of first aid measures

· General advice: Show this safety data sheet to the doctor in attendance.

· Eye contact: Immediately flush with plenty of water, remove contact lenses after initial flushing, continue flushing for at least 15 minutes, and get medical attention if irritation develops and persists.

· Skin contact: Wash off immediately with soap and plenty of water for at least 15 minutes, remove contaminated clothing, and get medical attention if irritation such as redness, rash, or blistering develops.

· Inhalation: Remove person to fresh air and keep them comfortable for breathing; if breathing is irregular or stopped, administer artificial respiration and get medical attention immediately by calling 999.

· Ingestion: Do NOT induce vomiting, call the National Poisons Information Service on +44 (0) 344 892 0111 immediately, and never give anything by mouth to an unconscious person.

4.2 Most important symptoms and effects, both acute and delayed

None under normal use conditions.

4.3 Indication of any immediate medical attention and special treatment needed

· Notes to physician: Treat symptomatically and follow advice by the NPIS/Toxbase.

Section 5: Fire fighting measures

5.1 Extinguishing media

· Suitable extinguishing media: Foam, carbon dioxide (CO2), dry chemical, and water spray; use extinguishing measures appropriate to local circumstances and the surrounding environment.

· Unsuitable extinguishing media: No information available.

5.2 Special hazards arising from the substance or mixture

Thermal decomposition can lead to release of irritating gases and vapours, and the product may emit toxic fumes under fire conditions.

5.3 Advice for firefighters

As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH approved or equivalent, and full protective gear; cool containers or tanks with water spray because sealed containers may rupture when heated.

Section 6: Accidental release measures

6.1 Personal precautions, protective equipment and emergency procedures

Remove all sources of ignition, ventilate the area, avoid contact with eyes, skin, and clothing, avoid breathing dust or vapor, evacuate personnel to safe areas, and keep people away from and upwind of spill or leak.

6.2 Environmental precautions

Prevent product from entering drains, prevent further leakage or spillage if safe to do so, keep out of drains, sewers, ditches, and waterways, and advise local authorities if significant spillages cannot be contained.

6.3 Methods and material for containment and cleaning up

Contain spillage, collect with non-combustible absorbent material such as sand, earth, diatomaceous earth, or vermiculite, place in a container for disposal according to local or national regulations, and use clean non-sparking tools to collect absorbed material.

6.4 Reference to other sections

See Section 12 for more information.

Section 7: Handling and storage

7.1 Precautions for safe handling

Use personal protective equipment as required, do not eat, drink, or smoke when using this product, and ensure adequate ventilation.

7.2 Conditions for safe storage, including any incompatibilities

Keep containers tightly closed in a dry, cool, and well-ventilated place, keep away from open flames, hot surfaces, and sources of ignition, keep container closed when not in use, and keep out of the reach of children.

7.3 Specific end use(s)

· Exposure scenario: No information available.

· Risk Management Methods (RMM): The information required is contained in this Safety Data Sheet.

Section 8: Exposure controls/personal protection

8.1 Control parameters

Exposure limits, DNEL values, and related occupational exposure information are reproduced from the source SDS, including values for the European Union, United Kingdom, France, Germany, Spain, Italy, Portugal, Netherlands, Finland, Denmark, Austria, Switzerland, Poland, Norway, Ireland, and Australia.

Because the original Section 8 contains extensive tabulated exposure data across multiple jurisdictions, the same values should be treated as part of this rebranded SDS record and verified for current applicability before formal issue.

Derived No Effect Level (DNEL)

Chemical name

DNEL - Dermal (Workers)

DNEL - Inhalation (Workers)

Xylenes (o-, m-, p- isomers) 1330-20-7

212 mg/kg (Systemic acute/short term)

221 mg/m3 (Systemic long term); 442 mg/m3 (Systemic acute/short term); 221 mg/m3 (Local long term); 442 mg/m3 (Local acute/short term)

Ethyl benzene (constituent) 100-41-4

180 mg/kg (Systemic long term)

77 mg/m3 (Systemic long term); 293 mg/m3 (Local acute/short term)

Cumene (constituent) 98-82-8

15.4 mg/kg (Systemic long term)

100 mg/m3 (Systemic long term); 250 mg/m3 (Local acute/short term)

Predicted No Effect Concentration (PNEC): No information available.

8.2 Exposure controls

· Engineering measures: Provide a good standard of general ventilation; natural ventilation is from doors, windows, etc.; controlled ventilation means air is supplied or removed by a powered fan; users are advised to consider national Occupational Exposure Limits or equivalent values; in case of insufficient ventilation, wear suitable respiratory equipment.

· Eye/face protection: Wear safety glasses with side shields or goggles, wear a suitable face shield if splashes are likely, and ensure eyewash stations and safety showers are close to the workstation location.

· Skin protection: Wear impervious protective clothing including boots, gloves, lab coat, apron, or coveralls as appropriate to prevent skin contact.

· Hand protection: Use chemical resistant protective gloves; suitable prolonged-contact materials include nitrile rubber (0.4 mm), chloroprene rubber (0.5 mm), and polyvinylchloride (0.7 mm), with recommended protective index 6 corresponding to more than 480 minutes permeation time, subject to actual use conditions and manufacturer instructions.

· Respiratory protection: If exposure limits are exceeded or irritation is experienced, wear approved respiratory protection in accordance with current local regulations, with selection dependent on the operation and potential airborne concentration.

· General hygiene considerations: Handle in accordance with good industrial hygiene and safety practice, wash hands before eating, drinking, or smoking, wash contaminated clothing before reuse, avoid contact with eyes, skin, and clothing, wear suitable gloves and eye/face protection, and regularly clean equipment, work area, and clothing.

· Environmental exposure controls: No information available.

Section 9: Physical and chemical properties

9.1 Information on basic physical and chemical properties

Physical state: Liquid

Appearance: Water-white

Odour: No information available

Odour threshold: No information available

Melting point / freezing point: No data available

Initial boiling point and boiling range: > 149 °C

Flammability: No data available

Upper flammability or explosive limits: No data available

Lower flammability or explosive limits: No data available

Flash point: 27 °C

Autoignition temperature: No data available

Decomposition temperature: None known

pH: No data available

pH (as aqueous solution): No data available

Kinematic viscosity: No data available

Dynamic viscosity: No data available

Water solubility: No data available

Solubility(ies): No data available

Partition coefficient: No data available

Vapor pressure: No data available

Relative density: 0.89

Bulk density: No data available

Liquid density: No data available

Relative vapor density: No data available

Particle size: No data available

Particle size distribution: No data available

9.2 Other information

· Information with regard to physical hazard classes: Not applicable.

· Other safety characteristics: No information available.

Section 10: Stability and reactivity

· Reactivity: No information available.

· Chemical stability: Stable under normal conditions.

· Possibility of hazardous reactions: None under normal processing.

· Conditions to avoid: Keep away from open flames, hot surfaces, and sources of ignition.

· Incompatible materials: Strong acids, strong bases, strong oxidizing agents, and reducing agent.

· Hazardous decomposition products: Thermal decomposition can lead to release of irritating gases and vapours, carbon dioxide (CO2), and carbon monoxide.

Section 11: Toxicological information

11.1 Information on toxicological effects

· Inhalation: Specific test data for the substance or mixture is not available; toxic if inhaled and harmful if inhaled based on components.

· Eye contact: Specific test data for the substance or mixture is not available.

· Skin contact: Specific test data for the substance or mixture is not available; harmful in contact with skin based on components.

· Ingestion: Specific test data for the substance or mixture is not available.

· Unknown acute toxicity: 0% of the mixture consists of ingredient(s) of unknown acute toxicity, including oral, dermal, inhalation gas, inhalation vapor, and inhalation dust/mist toxicity.

ATEmix values calculated based on chapter 3.1 of the GHS document:

· ATEmix (oral): 99,999.00

· ATEmix (dermal): 1,198.90

· ATEmix (inhalation-gas): 99,999.00

· ATEmix (inhalation-dust/mist): 1.36

· ATEmix (inhalation-vapor): 9.99

Chemical name

Oral LD50

Xylenes (o-, m-, p- isomers) 1330-20-7 = 3500 mg/kg (Rat)

Ethyl benzene (constituent) 100-41-4 = 3500 mg/kg (Rat)

Cumene (constituent) 98-82-8 = 1400 mg/kg (Rat)

Chemical name

Dermal LD50

Xylenes (o-, m-, p- isomers) 1330-20-7

> 4350 mg/kg (Rabbit)

Ethyl benzene (constituent) 100-41-4

= 15400 mg/kg (Rabbit)

Cumene (constituent) 98-82-8

= 12300 µL/kg (Rabbit)

Chemical name

Inhalation LC5

---

Xylenes (o-, m-, p- isomers) 1330-20-7 = 29.08 mg/L (Rat) 4 h

Ethyl benzene (constituent) 100-41-4 = 17.4 mg/L (Rat) 4 h

Cumene (constituent) 98-82-8 > 3577 ppm (Rat) 6 h

· Skin corrosion/irritation: Specific test data for the substance or mixture is not available; skin irritation with pain, redness, and swelling based on components.

· Eye damage/irritation: Specific test data for the substance or mixture is not available.

· Sensitization: Specific test data for the substance or mixture is not available.

· Mutagenic effects: Specific test data for the substance or mixture is not available.

· Carcinogenic effects: Specific test data for the substance or mixture is not available; may cause cancer based on components.

· Reproductive effects: Specific test data for the substance or mixture is not available.

· CMR, categories 1 and 2: This product contains one or more substances classified in the EU as carcinogenic, mutagenic and/or reprotoxic; cumene is classified as Carc. 1B.

· STOT - single exposure: Specific test data for the substance or mixture is not available.

· STOT - repeated exposure: Specific test data for the substance or mixture is not available; may cause damage to organs through prolonged or repeated exposure based on components.

· Aspiration hazard: Specific test data for the substance or mixture is not available; may be fatal if swallowed and enters airways based on components.

11.2 Information on other hazards

No information available.

Section 12: Ecological information

12.1 Toxicity

Specific test data for the substance or mixture is not available, and the product contains 0% of components with unknown hazards to the aquatic environment.

12.2 Persistence and degradability

No information available.

12.3 Bioaccumulative potential

Chemical name

Partition coefficient

Xylenes (o-, m-, p- isomers) 1330-20-7

3.15

Ethyl benzene (constituent) 100-41-4

3.2

Cumene (constituent) 98-82-8

3.7

12.4 Mobility in soil

No information available.

12.5 Results of PBT and vPvB assessment

This mixture contains no substance considered to be persistent, bioaccumulating nor toxic (PBT), and no substance considered to be very persistent nor very bioaccumulating (vPvB).

12.6 Endocrine disrupting properties

This product does not contain any known or suspected endocrine disruptors.

12.7 Other adverse effects

No information available.

Section 13: Disposal considerations

13.1 Waste treatment methods

· Waste from residues/unused products: Contain and dispose of waste according to local regulations.

· Contaminated packaging: Empty containers should be taken to an approved waste handling site for recycling or disposal.

Section 14: Transport information

This information is not intended to convey all specific transportation requirements relating to this product; transportation classifications may vary by container volume and may be influenced by regional or country variations in regulations, and it is the responsibility of the transporting organization to follow all applicable laws, regulations, and rules relating to transportation of the material.

ADR

· UN number or ID number: UN1210

· UN proper shipping name: Printing Ink Related Material

· Transport hazard class(es): 3

· Packing group: III

ICAO / IATA / IMDG / IMO

· UN number or ID number: UN1210

· UN proper shipping name: Printing Ink Related Material

· Transport hazard class(es): 3

· Packing group: III

Section 15: Regulatory information

15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture

· European Union

· International Inventories: For further information, please contact supplier (manufacturer/importer/downstream user/distributor)

· Regulation (EC) No. 1907/2006 (REACH), Article 57: This product does not contain candidate substances of very high concern at a concentration >=0.1% under Regulation (EC) No. 1907/2006 (REACH), Article 59.

15.2 Chemical safety assessment

No information available.

Section 16: Other information

Full text of H-statements referred to under section 3 :

· H225 - Highly flammable liquid and vapor

· H226 - Flammable liquid and vapor

· H304 - May be fatal if swallowed and enters airways

· H312 - Harmful in contact with skin

· H315 - Causes skin irritation

· H332 - Harmful if inhaled

· H335 - May cause respiratory irritation

· H350 - May cause cancer

· H373 - May cause damage to organs through prolonged or repeated exposure

· H411 - Toxic to aquatic life with long lasting effects


Safety Data Sheet according to Regulation (EC) No. 1907/2006 (REACH).

Disclaimer

The information provided in this Safety Data Sheet is correct to the best of the source publisher's knowledge, information, and belief at the date of publication, and is designed only as guidance for safe handling, use, processing, storage, transportation, disposal, and release; it is not to be considered a warranty or quality specification, and it relates only to the specific material designated and may not be valid for such material used in combination with any other materials or in any process unless specified in the text .

End of Safety Data Sheet

Contact

Reach out to us!

Email

Phone

office@sprintmedical.co.uk

+44 333 335 6556

© 2026. All rights reserved. SPRInt Medical Group Limited.

ADDRESS

Office 103, 46-95 Southampton Way, SE5 7SW, London, UK